Overall rank by patents
#20,309
of 49,997 tracked assignees
USPTO PatentsView assignee record - 14 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A41C (CORSETS; Brassieres).
The verdict
According to USPTO PatentsView, Regina ranks #20,309 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 13 technology areas.
USPTO PatentsView assignee plate
Corpus R20309 · Foreign Corporation #20,309 · 14 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: Reavire, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Regina Miracle… · this assignee
43 score
3D Lighting… · lowest
7 score
What this shows Regina's Innovation Score is 43.2/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Regina Miracle International (Group) Limited is a focused PatentsView assignee: 13 CPC subclasses with 85.7% of grants classified under A41C (CORSETS; Brassieres). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2016. By volume, Regina sits between ReShape Medical LLC and ResnENT, LLC.
Regina Miracle International (Group) Limited shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ReShape Medical LLC
14 patents
Reavire, Inc.
14 patents
Rebate Assets, LLC
14 patents
RedMed Limited
14 patents
Relativity Space, Inc.
14 patents
Renu Therapy, LLC
14 patents
Resense GmbH
14 patents
ResnENT, LLC
14 patents
Regina Miracle International (Group) Limited
14 patents
What this shows Regina holds 14 patents at rank #20,327, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #20,327 in granted patent volume.
Other assignees with the most granted patents in Regina's primary technology class.
Regina's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 14.3% |
| 2016 | 1 | 7.1% |
| 2018 | 2 | 14.3% |
| 2019 | 1 | 7.1% |
| 2020 | 1 | 7.1% |
| 2021 | 1 | 7.1% |
| 2023 | 1 | 7.1% |
| 2024 | 4 | 28.6% |
| 2025partial year | 1 | 7.1% |
Top 13 of 13 technology areas
Overall rank by patents
#20,309
of 49,997 tracked assignees
43.2 out of 100
What to do with this data
Regina Miracle International (Group) Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.